标题/作者	年份
Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer G Gonzalez-Avila, B Sommer, DA Mendoza-Posada, C Ramos, ... Critical reviews in oncology/hematology 137, 57-83	2019
Hyaluronan: molecular size‐dependent signaling and biological functions in inflammation and cancer AG Tavianatou, I Caon, M Franchi, Z Piperigkou, D Galesso, ... The FEBS journal 286 (15), 2883-2908	2019
Hyaluronan biology: A complex balancing act of structure, function, location and context S Garantziotis, RC Savani Matrix Biology 78, 1-10	2019
Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis I Pastushenko, F Mauri, Y Song, F de Cock, B Meeusen, B Swedlund, ... Nature 589 (7842), 448-455	2021
Strategies for hyaluronic acid-based hydrogel design in drug delivery S Trombino, C Servidio, F Curcio, R Cassano Pharmaceutics 11 (8), 407	2019
Targeting cancer stem cells for reversing therapy resistance: Mechanism, signaling, and prospective agents HM Zhou, JG Zhang, X Zhang, Q Li Signal transduction and targeted therapy 6 (1), 62	2021
CD44 as a tumor biomarker and therapeutic target H Xu, M Niu, X Yuan, K Wu, A Liu Experimental Hematology & Oncology 9 (1), 1-14	2020
Cocktail strategy based on spatio‐temporally controlled nano device improves therapy of breast cancer T Lang, Y Liu, Z Zheng, W Ran, Y Zhai, Q Yin, P Zhang, Y Li Advanced Materials 31 (5), 1806202	2019
EMT‐associated microRNAs and their roles in cancer stemness and drug resistance G Pan, Y Liu, L Shang, F Zhou, S Yang Cancer Communications 41 (3), 199-217	2021
Towards applications of [email protected] MOFs in biomedicine MJ Velásquez-Hernández, M Linares-Moreau, E Astria, F Carraro, ... Coordination Chemistry Reviews 429, 213651	2021
Recent advances in MOF-based nanoplatforms generating reactive species for chemodynamic therapy Y Zhong, X Li, J Chen, X Wang, L Wei, L Fang, A Kumar, SZ Zhuang, J Liu Dalton Transactions 49 (32), 11045-11058	2020
Next-generation cancer organoids BL LeSavage, RA Suhar, N Broguiere, MP Lutolf, SC Heilshorn Nature materials 21 (2), 143-159	2022
CD44v6 engages in colorectal cancer progression L Ma, L Dong, P Chang Cell death & disease 10 (1), 30	2019
Cancer metastasis: the role of the extracellular matrix and the heparan sulfate proteoglycan perlecan Z Elgundi, M Papanicolaou, G Major, TR Cox, J Melrose, JM Whitelock, ... Frontiers in oncology 9, 1482	2020
Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer Y Liang, Y Wang, L Wang, Z Liang, D Li, X Xu, Y Chen, X Yang, H Zhang, ... Bioactive materials 6 (2), 433-446	2021
Drug resistance in cancer: mechanisms and tackling strategies T Haider, V Pandey, N Banjare, PN Gupta, V Soni Pharmacological Reports 72 (5), 1125-1151	2020
Markers of pancreatic cancer stem cells and their clinical and therapeutic implications A Gzil, I Zarębska, W Bursiewicz, P Antosik, D Grzanka, Ł Szylberg Molecular biology reports 46, 6629-6645	2019
Smart targeting to improve cancer therapeutics M Morales-Cruz, Y Delgado, B Castillo, CM Figueroa, AM Molina, ... Drug design, development and therapy, 3753-3772	2019
CD44: A multifunctional mediator of cancer progression M Hassn Mesrati, SE Syafruddin, MA Mohtar, A Syahir Biomolecules 11 (12), 1850	2021
Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance R Pothuraju, S Rachagani, SR Krishn, S Chaudhary, RK Nimmakayala, ... Molecular cancer 19, 1-14	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。